Reply to Editorial Comment on “Impact of GLP-1 Receptor Agonists on Male Fertility: Emerging Evidence and Future Directions”
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Editorial Comment on “Impact of Glucagon-Like Peptide-1 Receptor Agonists on Male Fertility: Emerging Evidence and Future Directions”Urology, 2025
- Managing obesity-related male infertility: insights from weight loss interventionHuman Reproduction, 2025
- GLP-1 receptor agonists show no detrimental effect on sperm quality in mouse models and cell linesEndocrine, 2025
- Role of PI3K/AKT signaling pathway during capacitationTheriogenology, 2025
- Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadismDiabetes, Obesity and Metabolism, 2024
- Liraglutide improved the reproductive function of obese mice by upregulating the testicular AC3/cAMP/PKA pathwayReproductive Biology and Endocrinology, 2024
- Long‐acting glucagon‐like peptide 1 receptor agonists boost erectile function in men with type 2 diabetes mellitus complaining of erectile dysfunction: A retrospective cohort studyAndrology, 2023
- Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trialHuman Reproduction, 2022
- Glucagon‐like peptide‐1 receptor is expressed in human and rodent testisAndrology, 2020
- Metabolic dynamics of human Sertoli cells are differentially modulated by physiological and pharmacological concentrations of GLP-1Toxicology and Applied Pharmacology, 2019